MDxHealth Reports Q1-2023 Results
NEWS RELEASE – REGULATED INFORMATION15 MAY 2023, 4:00PM EDT / 22:00 CET MDxHealth…
Social Media
Domo Announces Timing of its First Quarter Fiscal 2024 Earnings Conference Call
SILICON SLOPES, Utah–(BUSINESS WIRE)–Domo (Nasdaq: DOMO) today announced that results for its first quarter fiscal…
Orchard Therapeutics Reports First Quarter 2023 Financial Results and Announces Initiation of Rolling Submission for Biologics License Application of OTL-200 for Metachromatic Leukodystrophy to U.S. FDA
OTL-200 Biologics License Application (BLA) submission completion anticipated in mid-2023 Libmeldy revenue and commercial patients…
Cellectis Publishes Article in Frontiers in Immunology Unveiling Pre-Clinical Data on a Novel Treatment Paradigm for Successful CAR T Immunotherapy Against Stroma-rich Solid Tumors
NEW YORK, May 12, 2023 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS –…
Cellectis Publishes Article in Frontiers in Immunology Unveiling Pre-Clinical Data on a Novel Treatment Paradigm for Successful CAR T Immunotherapy Against Stroma-rich Solid Tumors
NEW YORK, May 12, 2023 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS –…
BRC Inc. Reports First Quarter 2023 Financial Results
Net Revenue Increases 27% in Q1 2023 to $83.5 million, Led by Wholesale Growth of…
Cellectis Announces Poster Presentation on BALLI-01 at the European Hematology Association (EHA) 2023
BALLI-01 (evaluating UCART22) abstract demonstrates safety and preliminary efficacy of UCART22 in heavily pretreated r/r…
Cellectis Announces Poster Presentation on BALLI-01 at the European Hematology Association (EHA) 2023
BALLI-01 (evaluating UCART22) abstract demonstrates safety and preliminary efficacy of UCART22 in heavily pretreated r/r…
DatChat Launches the Habytat Mobile Metaverse for the Masses
Habytat Offers Free NFT Deeded Metaverse Property and Houses to Users NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–DatChat…
Mithra Announces Completion of Recruitment in Pediatric Study of Estelle in Adolescent Patients
Mithra Announces Completion of Recruitment in Pediatric Study of Estelle in Adolescent Patients Trial designed…
Intradiem Awarded UK Patent for Technology to Expand Call Centre Data-Handling Capabilities
ATLANTA–(BUSINESS WIRE)–Intradiem, the leading provider of intelligent automation solutions for contact centre and back-office customer…
Nutanix Announces Nutanix Central, Cloud to Edge Management Solution
Company will extend universal cloud operating model to consistently run apps and data anywhere CHICAGO–(BUSINESS…
Nutanix Unifies Data Services Across Hybrid Multicloud Environments
Company announces data services for Kubernetes and cross-cloud data mobility CHICAGO–(BUSINESS WIRE)–#HCI—.NEXT Conference – Nutanix…
Sandoz strengthens pipeline expansion through partnership to develop and manufacture multiple biosimilars
Sandoz and Just – Evotec Biologics announce partnership to develop and manufacture multiple biosimilars with…
Wolters Kluwer offers risk and compliance insights on recent bank failures
Recently published commentaries offer context, perspective in wake of banking disruptions MINNEAPOLIS–(BUSINESS WIRE)–#bankfailures–Recently published commentary…
Convergent Energy and Power Ranks Among Highest-Scoring Businesses on Inc. Magazine’s Annual List of Best Workplaces for 2023
NEW YORK–(BUSINESS WIRE)–Convergent Energy and Power (Convergent), a leading provider of energy storage solutions in…
New Research Shows Teens are Re-Thinking the Future of Work
JA/Citizens 2023 Survey of High School Students Reveals Their Career Aspirations; Economic and College Concerns;…
Annaly Capital Management, Inc. Reports 1st Quarter 2023 Results
NEW YORK–(BUSINESS WIRE)–Annaly Capital Management, Inc. (NYSE: NLY) (“Annaly” or the “Company”) today announced its…
Regeneron and Alnylam Report Positive Interim Phase 1 Clinical Data on ALN-APP, an Investigational RNAi Therapeutic for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
– Single Doses of ALN-APP Demonstrated Dose-Dependent, Rapid and Sustained Reduction of sAPPα and sAPPβ…
HOOKIPA to Present a Trial in Progress Poster on its Prostate Cancer Phase 1/2 Clinical Trial at ASCO
NEW YORK and VIENNA, Austria, April 26, 2023 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ:…